相似文献
1
Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers.
Gut. 1991 Feb;32(2):151-3. doi: 10.1136/gut.32.2.151.
2
Ranitidine maintenance therapy in the prevention of duodenal ulceration; a comparison of 150 mg at night with 300 mg at night.
Aliment Pharmacol Ther. 1995 Jun;9(3):287-91. doi: 10.1111/j.1365-2036.1995.tb00383.x.
3
Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group.
Z Gastroenterol. 1995 Sep;33(9):509-12.
4
Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer.
Am J Med. 1984 Nov 19;77(5B):39-42.
5
Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night.
Gut. 1986 Sep;27(9):1091-5. doi: 10.1136/gut.27.9.1091.
6
Ranitidine: prophylaxis of duodenal ulcer recurrence.
Hepatogastroenterology. 1984 Apr;31(2):85-7.
7
Early evening dosing of ranitidine. Comparison with nighttime dosing of ranitidine or cimetidine in duodenal ulceration.
Dig Dis Sci. 1993 Aug;38(8):1459-67. doi: 10.1007/BF01308604.
8
[Dose comparative study with ranitidine in the therapy and prevention of duodenal ulcer].
Z Gastroenterol. 1986 Mar;24(3):141-8.
9
Prevention of duodenal ulcer relapse with ranitidine.
S Afr Med J. 1985 Sep 14;68(6):385-6.
10
A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse.
Aliment Pharmacol Ther. 1991 Apr;5(2):181-9. doi: 10.1111/j.1365-2036.1991.tb00019.x.
引用本文的文献
1
Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
Drugs Aging. 1996 Oct;9(4):251-61. doi: 10.2165/00002512-199609040-00003.
2
Prescribing policy for antiulcer treatment in the elderly.
Drugs Aging. 1993 Jul-Aug;3(4):308-19. doi: 10.2165/00002512-199303040-00002.
3
Clinical pharmacology and therapeutics.
Postgrad Med J. 1991 Dec;67(794):1042-54. doi: 10.1136/pgmj.67.794.1042.
本文引用的文献
1
Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study.
Postgrad Med J. 1980 Mar;56(653):173-6. doi: 10.1136/pgmj.56.653.173.
2
Ranitidine: prophylaxis of duodenal ulcer recurrence.
Hepatogastroenterology. 1984 Apr;31(2):85-7.
3
Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
Lancet. 1984 Sep 22;2(8404):659-62. doi: 10.1016/s0140-6736(84)91224-8.
4
Model of medical treatment for duodenal ulcer.
Lancet. 1981 Jan 3;1(8210):29-30. doi: 10.1016/s0140-6736(81)90128-8.
5
Comparison of ranitidine and cimetidine ulcer maintenance therapy.
J Clin Gastroenterol. 1987 Dec;9(6):644-50. doi: 10.1097/00004836-198712000-00007.
6
The effects of cigarette smoking on plasma concentrations of gastric antisecretory drugs.
Aliment Pharmacol Ther. 1987 Feb;1(1):57-65. doi: 10.1111/j.1365-2036.1987.tb00607.x.
7
Recurrence of duodenal ulcer after medical treatment.
Lancet. 1988 May 21;1(8595):1147-9. doi: 10.1016/s0140-6736(88)91961-7.
8
Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study.
Am J Med. 1986 Oct 24;81(4B):25-32. doi: 10.1016/0002-9343(86)90597-8.
9
Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
Lancet. 1985 Jun 8;1(8441):1299-302. doi: 10.1016/s0140-6736(85)92793-x.
Zotero 插件